VOLITIONRX LTD Cash Flow Statement
VNRX|10 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
VOLITIONRX LTD used $26M in operating cash flow and negative free cash flow of $26M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$27.0M | -$35.7M | -$30.6M | -$27.0M | -$20.4M | -$16.1M | -$18.0M | -$3.7M | -$3.5M | -$3.5M |
| Depreciation & Amortization | $1.1M | $1.2M | $936.1K | $945.4K | $716.2K | $676.8K | $636.4K | $146.4K | $135.7K | $118.6K |
| Operating Cash Flow | -$25.9M | -$18.1M | -$15.3M | -$20.9M | -$16.5M | -$12.7M | -$14.7M | -$3.1M | -$2.3M | -$1.7M |
| Capital Expenditures | $277.5K | $1.1M | $1.6M | $973.6K | $1.9M | $511.3K | -$301.8K | $714 | $90.7K | $34.9K |
| Free Cash Flow | -$26.2M | -$19.1M | -$16.8M | -$21.8M | -$18.4M | -$13.3M | -$14.4M | -$3.1M | -$2.4M | -$1.7M |
| Share Buybacks | - | $31.8K | $0 | - | - | - | - | - | - | - |
| FCF Margin | -2121.7% | -2469.6% | -5498.8% | -24243.3% | -137015.6% | -77507.7% | -84412.9% | -20865.2% | -4375.8% | -3069.6% |